Technical Analysis for TENX - Tenax Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 1.84 -6.12% -0.12
TENX closed down 6.12 percent on Friday, March 22, 2019, on 81 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Up Down
See historical TENX trend table...

Date Alert Name Type % Chg
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Outside Day Range Expansion 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 22 Down 4 Days in a Row Weakness 0.00%
Mar 21 1,2,3 Pullback Bullish Bullish Swing Setup -6.12%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.12%
Mar 21 Wide Bands Range Expansion -6.12%
Mar 21 Down 3 Days in a Row Weakness -6.12%

Older signals for TENX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company also develops Oxycyte, a systemic perfluorocarbon product for use as oxygen carrier in the situations of acute ischemia; and a range of perfluorocarbon-based oxygen carriers for use in personal care, topical wound healing, and other topical indications. Its Oxycyte is under Phase II-b clinical trials for the treatment of traumatic brain injury. In addition, the company offers Dermacyte line of topical cosmetic products that promote the appearance of skin health and other cosmetic benefits; and Wundecyte, a wound-healing gel. It sells Dermacyte through distribution agreements, on-line retailers, and direct sales to physician and medical spa facilities. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Medicine Pharmaceutical Pharmaceutical Products Pharmacology Cardiac Surgery Topical Medication Oxycyte Traumatic Brain Injury Wound Healing
Is TENX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 11.92
52 Week Low 1.03
Average Volume 1,248,880
200-Day Moving Average 3.8977
50-Day Moving Average 1.399
20-Day Moving Average 1.647
10-Day Moving Average 1.884
Average True Range 0.3124
ADX 61.56
+DI 36.756
-DI 5.8037
Chandelier Exit (Long, 3 ATRs ) 1.8528
Chandelier Exit (Short, 3 ATRs ) 2.1172
Upper Bollinger Band 2.2928
Lower Bollinger Band 1.0012
Percent B (%b) 0.65
BandWidth 78.421372
MACD Line 0.1758
MACD Signal Line 0.1522
MACD Histogram 0.0236
Fundamentals Value
Market Cap 51.96 Million
Num Shares 28.2 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -1.29
Price-to-Sales 0.00
Price-to-Book 1.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.37
Resistance 3 (R3) 2.41 2.28 2.28
Resistance 2 (R2) 2.28 2.15 2.26 2.25
Resistance 1 (R1) 2.06 2.06 2.00 2.02 2.22
Pivot Point 1.93 1.93 1.90 1.91 1.93
Support 1 (S1) 1.71 1.80 1.65 1.67 1.46
Support 2 (S2) 1.58 1.71 1.56 1.43
Support 3 (S3) 1.36 1.58 1.40
Support 4 (S4) 1.32